COMP <GO>
AVGO vs MRVL // RSI-14 & 200D SMA MOMENTUM
Broadcom Inc. (NASDAQ) VS. Marvell Technology Inc. (NASDAQ) • 15-METRIC TALLY: AVGO 12
— MRVL 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: AVGO
LAST: $326.08 (-5.48%) • MKT CAP: $1.65T
rsi-technicals
46.1
LAST: $196.40 (-10.05%) • MKT CAP: $191.46B
rsi-technicals
42.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVGO VS. MRVL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVGO | MRVL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.77% | 51.00% | +17.77 | AVGO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.73% | 6.70% | +18.03 | AVGO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.4x | 95.0x | -60.65 | AVGO | /valuation <GO> |
| Free Cash Flow Yield | 2.53% | 0.73% | +1.80 | AVGO | /fcf-yield <GO> |
| Operating Margin | 48.05% | 16.10% | +31.95 | AVGO | /operating-margins <GO> |
| Net Profit Margin | 42.94% | 32.60% | +10.34 | AVGO | /net-margins <GO> |
| Revenue Growth (YoY) | 48.69% | 42.10% | +6.59 | AVGO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.80% | 0.11% | +0.69 | AVGO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.15 | 15.22 | -3.07 | MRVL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.98% | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 46.1 | 42.9 | +3.20 | AVGO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.82 | 1.15 | +0.67 | AVGO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.0x | 60.2x | -43.21 | AVGO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.65T | $191.46B | $1.46T | AVGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVGO REV | MRVL REV | AVGO GROSS % | MRVL GROSS % | AVGO FCF | MRVL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $63.89B | $8.19B | 67.8% | 51.0% | $26.91B | $1.40B |
| FY 2024 | $51.57B | $5.77B | 63.0% | 41.3% | $19.41B | $1.40B |
| FY 2023 | $35.82B | $5.51B | 68.9% | — | $17.63B | $1.12B |
| FY 2022 | $33.20B | — | 66.5% | — | $16.31B | — |
| FY 2021 | $27.45B | — | 61.4% | — | $13.32B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVGO // BETA 1.82
MRVL // BETA 1.15